Suchen
WAVE Life Sciences Ltd
WVEZur Watchlist hinzufügen
5.510USD
-0.250-4.34%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
1.09BMarktkapitalisierung
VerlustKGV TTM
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
RA Capital Management, LP
14.02%
GSK plc
9.48%
Fidelity Management & Research Company LLC
7.10%
BlackRock Institutional Trust Company, N.A.
5.21%
Adage Capital Management, L.P.
5.09%
Andere
59.11%
Aktionäre
Aktionäre
Anteil
RA Capital Management, LP
14.02%
GSK plc
9.48%
Fidelity Management & Research Company LLC
7.10%
BlackRock Institutional Trust Company, N.A.
5.21%
Adage Capital Management, L.P.
5.09%
Andere
59.11%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
34.60%
Hedge Fund
22.19%
Investment Advisor/Hedge Fund
18.68%
Corporation
15.45%
Venture Capital
14.10%
Research Firm
1.78%
Individual Investor
0.43%
Bank and Trust
0.31%
Pension Fund
0.18%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
342
144.00M
77.83%
--
2026Q1
433
180.16M
93.64%
+29.09M
2025Q4
393
146.58M
80.21%
+2.16M
2025Q3
368
140.86M
88.47%
+5.01M
2025Q2
364
156.69M
98.46%
-1.61M
2025Q1
368
156.82M
101.38%
+1.16M
2024Q4
342
152.89M
100.27%
+6.14M
2024Q3
306
144.44M
97.59%
+25.71M
2024Q2
274
116.00M
94.13%
+429.46K
2024Q1
255
115.83M
95.69%
+2.66M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
RA Capital Management, LP
26.99M
14.34%
+8.79M
+48.28%
Mar 30, 2026
GSK plc
18.25M
9.69%
+1.47M
+8.76%
Dec 31, 2025
Fidelity Management & Research Company LLC
13.65M
7.25%
+9.36M
+218.18%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.02M
5.32%
+1.29M
+14.77%
Dec 31, 2025
Adage Capital Management, L.P.
9.79M
5.2%
-4.78M
-32.82%
Dec 31, 2025
Shin Nippon Biomedical Laboratories Ltd
5.71M
3.03%
--
--
Jun 06, 2025
Maverick Capital, Ltd.
9.28M
4.93%
+888.38K
+10.59%
Dec 31, 2025
Darwin Global Management Ltd
7.30M
3.88%
+7.30M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
7.26M
3.86%
+3.35M
+85.76%
Dec 31, 2025
Driehaus Capital Management, LLC
6.58M
3.5%
+283.01K
+4.49%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Pharmaceuticals ETF
1.81%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.34%
Global X Genomics & Biotechnology ETF
1.25%
Virtus LifeSci Biotech Clinical Trials ETF
0.85%
iShares U.S. Pharmaceuticals ETF
0.41%
First Trust Multi-Manager Small Cap Opportunities ETF
0.26%
iShares Micro-Cap ETF
0.19%
Franklin Genomic Advancements ETF
0.19%
ProShares Ultra Nasdaq Biotechnology
0.15%
Invesco Nasdaq Biotechnology ETF
0.14%
Mehr Anzeigen
State Street SPDR S&P Pharmaceuticals ETF
Anteil1.81%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil1.34%
Global X Genomics & Biotechnology ETF
Anteil1.25%
Virtus LifeSci Biotech Clinical Trials ETF
Anteil0.85%
iShares U.S. Pharmaceuticals ETF
Anteil0.41%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.26%
iShares Micro-Cap ETF
Anteil0.19%
Franklin Genomic Advancements ETF
Anteil0.19%
ProShares Ultra Nasdaq Biotechnology
Anteil0.15%
Invesco Nasdaq Biotechnology ETF
Anteil0.14%